Stay updated with breaking news from Medicinal Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OXFORD • John D. Ludwig, senior vice president for medicinal sciences at Pfizer Inc., is set to deliver the 2022 Coy W. Waller Distinguished Lecture at the University of Mississippi.
GlaxoSmithKline appoints Tony Wood as CSO Designate
Expert cites need to work on in preparation for another pandemic
Coya Therapeutics™ Announces the Appointment of Anabella Villalobos, Ph.D. to its Board of Directors May 25, 2021 07:00 ET | Source: Coya Therapeutics Coya Therapeutics Houston, UNITED STATES HOUSTON, May 25, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc. (Coya™), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells (Tregs) and Treg-derived exosome therapeutics for neurodegenerative and autoimmune diseases, today announced that it has appointed Anabella Villalobos Ph.D., Head of...
MedCity News Read about news from Seven Bridges, Outcomes4Me, Carrum Health and more. Shares0 , developer of a free mobile app and platform to navigate cancer treatment and care, is expanding its patient offering with a medication tracker that makes regimens a core part of the app experience. When adding a medication, the Outcomes4Me app suggests regimens and drugs based on your diagnosis. The current app now houses over 8,000 drugs along with their respective drug information with the ability to search for any approved drug. This new tool pairs with the symptom tracker which helps patients...